Standout Papers

In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target 2017 2026 2020 2023 739
  1. In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target (2017)
    Robert T. Manguso, Hans W. Pope et al. Nature
  2. PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity (2017)
    Vikram R. Juneja, Kathleen A. McGuire et al. The Journal of Experimental Medicine

Immediate Impact

12 by Nobel laureates 13 from Science/Nature 75 standout
Sub-graph 1 of 19

Citing Papers

SOX17 enables immune evasion of early colorectal adenomas and cancers
2024 StandoutNature
LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunity
2024 Standout

Works of Vikram R. Juneja being referenced

PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance
2020
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
2017 StandoutNature

Author Peers

Author Last Decade Papers Cites
Vikram R. Juneja 1380 1405 911 19 2.5k
M. Ángela Aznar 1454 1493 696 23 2.4k
Cristina Puig-Saus 1334 984 682 18 2.0k
Helena Escuin-Ordinas 1361 1018 628 19 2.0k
Klara Balint 1360 1404 1175 20 2.7k
Jasreet Hundal 1933 2047 1278 20 3.0k
Sydney Gordon 1348 1685 719 10 2.7k
Serena S. Kwek 1491 1193 683 27 2.2k
Alex D. Waldman 1511 1456 921 14 2.8k
Joost Neijssen 1715 1512 1234 19 3.2k
Lucas Ferrari de Andrade 1541 1564 645 28 2.5k

All Works

Loading papers...

Rankless by CCL
2026